Financial Reporting/Disclosure
| Reporting Status |
U.S. Reporting: SEC Filer
|
| Audited Financials |
Audited |
| Latest Report |
Not Available |
| Regulatory Agency |
Not Available |
| CIK |
0001335105 |
| Fiscal Year End |
Not Available |
| OTC Market Tier |
OTCQB |
Profile Data
| SIC - Industry Classification |
2834 - Pharmaceutical preparations |
| Incorporated In: |
DE, USA |
| Year of Inc. |
Not Available |
| Employees |
Not Available |
Company Officers
| John S. Kovach |
CEO, Principal Acct. Officer, Principal Fin. Officer |
Company Directors
| John S. Kovach |
|
| Robert Royds |
|
Service Providers
Auditor/Accountant
Legal Counsel
Not Available
Investor Relations Firm
Not Available
LIXT Security Details
Share Structure
| Market Value1 |
$24,751,399 |
a/o May 23, 2012 |
| Shares Outstanding |
35,359,142 |
a/o Apr 30, 2012 |
| Float |
Not Available |
| Authorized Shares |
Not Available |
| Par Value |
0.001
|
Shareholders
| Shareholders of Record |
85 |
a/o Mar 29, 2012 |
Corporate Actions
|
Ex. Date |
Record Date |
Pay Date |
1Market Value calculated only for respective security
